News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
153 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17781)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
3 (143)
4 (183)
5 (189)
6 (172)
7 (117)
10 (143)
11 (169)
12 (140)
13 (169)
14 (99)
17 (76)
18 (162)
19 (154)
20 (169)
21 (143)
24 (153)
25 (163)
26 (185)
27 (193)
28 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Drug Development
Calithera Biosciences, Inc. Initiates Three Phase 1 Trials With First-In-Class Glutaminase Inhibitor CB-839 In Patients With Advanced Solid And Hematological Cancers
February 24, 2014
·
3 min read
Business
Welch Allyn And EarlySense Partnership Generates Wide Range Of Monitoring Solutions To Enhance Patient Safety
February 24, 2014
·
4 min read
Flailing ThromboGenics NV Considering Strategic Options
February 24, 2014
·
5 min read
Policy
Regeneron Pharmaceuticals, Inc. Announces FDA Acceptance Of EYLEA® (Aflibercept) Injection Supplemental Biologics License Application For The Treatment Of Macular Edema Following Branch Retinal Vein Occlusion
February 24, 2014
·
10 min read
GEA Pharma Systems Release: Continuous Pharmaceutical Processing: Anytime, Anywhere, Interphex
February 24, 2014
·
4 min read
Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) Announces Closing Of $10.5 Million Private Placement Of Common Shares
February 24, 2014
·
1 min read
Lone Star Bio
DNAtrix, Inc. Awarded $10.8 Million Grant By The Cancer Prevention And Research Institute Of Texas
February 24, 2014
·
1 min read
Business
Oxford Immunotec Limited Schedules Fourth Quarter And Full Year 2013 Earnings Release And Conference Call For March 4, 2014
February 24, 2014
·
2 min read
Biotech Beach
STAAR Surgical Company To Present At The 34th Annual Cowen and Company Health Care Conference
February 24, 2014
·
1 min read
Pharm Country
iCAD, Inc. To Present At The 2014 RBC Capital Markets’ Global Healthcare Conference
February 24, 2014
·
1 min read
Previous
12 of 16
Next
